MINNEAPOLIS (WCCO) — Hennepin Healthcare has launched two clinical trials for a drug to see if it will help COVID-19 patients.
The trials are being doing through the Hennepin Healthcare Research Institute.READ MORE: Itchy Eyes? Scratchy Throats? Allergies Likely Not To Blame This Summer
Researchers are studying the safety and efficacy of the drug remdesivir to treat hospitalized patients with moderate or severe cases of COVID-19. It’s an antiviral drug previously tested in Ebola patients.READ MORE: How Can People Limit Water Use At Home? Do Small Changes Make A Difference?
Around 1,000 patients around the world will be in the trial. About 70 of them could be through Hennepin Healthcare.MORE NEWS: Friends Remember Mack Motzko and Sam Schuneman, Killed In Orono Crash
“The clinical trials will help to determine if remdesivir is a safe and effective drug that can improve outcomes for patients diagnosed with COVID-19 here at Hennepin Healthcare and in the broader community,” principal investigator Dr. Jason Baker said.